SEC
Whistleblower
Attorneys

July 26, 2018

Robert Gadimian

Trading and Pricing

SANCTION AMOUNT: $1161000

Defendants: Robert Gadimian

Defendant, the former senior director of regulatory affairs for Puma Biotechnology, Inc., traded on material nonpublic (insider) information ahead of two company announcements regarding cancer drug trials.

Thank you for submitting some email to us.